NCT06917625

Brief Summary

The Chilean infant Nutrition Trial was a prospective, randomized, double-blind, controlled study conducted in Santiago, Chile, between 2016 and The study aimed to evaluate growth and body composition changes between birth and two years of age in a large sample of children who were randomized to receive either infant formula with or without added MFGM (milk fat globule membrane) through 12 months of age or received human milk as part of the reference group. In a subsample of 160 children, neurodevelopmental were assessed at 6 months and 24 months.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 11, 2025

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

March 24, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 8, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

April 8, 2025

Status Verified

April 1, 2025

Enrollment Period

10 months

First QC Date

March 24, 2025

Last Update Submit

April 2, 2025

Conditions

Keywords

early nutritionbrain development

Outcome Measures

Primary Outcomes (3)

  • To determine if intake of bMFGM during the first year improves brain structure at 9 ys.

    Low-Field MRI will be used to assess general brain growth and morphometry (total brain volume, whole-brain white and gray matter volume, and cortical and sub-cortical structure volumes) as well as myelination using myelin-sensitive MRI. For specific analysis will examine brain regions involved in EF, including prefrontal cortex, hippocampus, amygdala, thalamus, motor and somatosensory cortices, and auditory cortex ; and connecting white matter regions, including corpus callosum, cingulum, superior longitudinal fasciculus, and anterior thalamic radiations .The results will be expressed by mean volumetric measures calculate from the MRI data using validated FreeSurfer software and compared across the groups using an ANCOVA, controlling for variables of interest. Mean myelin measures will be calculated for each white matter pathway and to identify significant differences (express by grade of myelination)

    MRI assessment will be performed at 9 years old in a session of 45 minutes

  • To determine if intake of bMFGM during the first year improves EF measures by ERPs at 9ys.

    . To assess EF the Go No Go task will be performed with ERPs. The participant will ask to press a button when any letter appears (Go stimulus) except when the letter will be X (No Go stimulus). There will be 2 blocks: Block 1(40 trials) of Go stimulus and Block 2 (200 trials) of randomized Go and No Go stimuli. Neurophysiological responses will be recorded from 128 scalp sites using a recording system with a geodesic sensor net .For the ERP analysis, the major positive and negative peaks following stimulus onset will be identified. Statistical analyses were conducted with SPSS software version 25.0.1. Behavioral measures will be reaction time (ms) and accuracy (%). Electrophysiological results will be the peak amplitude (mµ) and latency (ms) for the waves N2 and P300.

    ERPs assessment will be performed at 9 years old in a a second session of 90 minutes .

  • To determine if intake of bMFGM during the first year improves EF measures by questionnaire EFECO.

    The questionnaire EFECO evaluates executive functions throughout conductual observation. The scale has 67 questions which measure seven different executive functions: cognitive flexibility, emotional control, planification capacity, organization, initiative and working memory. The quantification of each item goes from 0 to 3 according with one of these responses: Never, sometime, frequently, and very frequently. The higher score corresponds to a better EF. The questionnaire will be filled by the adult accompanying the participant during the ERP measurement and confirm that lives with the participant.

    EFECO will be answered by the adult that ERPs assessment will be performed at 9 years old in a a second session of 90 minutes .

Study Arms (1)

FM EM

During the first year of life the participants received 1. regular formula milk 2. enriched with Milk Fat Membrane Globule formula

Diagnostic Test: Imaging

Interventions

ImagingDIAGNOSTIC_TEST

The participants will be assessed with a brain MRI and will performed a neurophysiological test to evaluate executive functions

Also known as: Event related potential test
FM EM

Eligibility Criteria

Age10 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Study population was selected from the neighborhoods close to the installation of research institute. The area corresponds to the southeast of Santiago, Chile

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CINUT

Santiago, RM, Chile

Location

MeSH Terms

Interventions

Diagnostic Imaging

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Patricio Peirano, MD

    University of Chile

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Professor

Study Record Dates

First Submitted

March 24, 2025

First Posted

April 8, 2025

Study Start

March 11, 2025

Primary Completion

January 1, 2026

Study Completion

January 1, 2026

Last Updated

April 8, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

The data published in an article could be share with other researchers

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning 6 months and 1 year after the publication
Access Criteria
By a written request to the authors

Locations